Can you or any member of your pharmacy team list scenarios that increase the risk of suspect products entering the prescription drug supply chain? If not, it's time to learn.
Review scenarios and the guidance from the FDA on investigating and reporting suspect product here. Then download NCPA's DSCSA Compliance Checklist and SOP Guidance. If you need expert advice, visit DSCSA 360.
NCPA
